Horizon Financial Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-430
Closed -$17K 139
2021
Q3
$17K Sell
430
-860
-67% -$36K 0.01% 98
2021
Q2
$59K Hold
1,290
0.04% 78
2021
Q1
$54K Hold
1,290
0.05% 40
2020
Q4
$55K Hold
1,290
0.05% 37
2020
Q3
$34K Buy
+1,290
New +$35.9K 0.03% 41

Other funds holding HALO

Horizon Financial Services's HALO Position: Q4 2021 in Review

Horizon Financial Services sold out of Halozyme (HALO) in Q4 2021, closing a stake of 430 shares — an estimated $17K sold.

Horizon Financial Services first reported a position in HALO in Q3 2020 and held it in 5 quarters. The position peaked at $59K in Q2 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q4 2021.

  • Horizon Financial Services reported no remaining Halozyme position as of Q4 2021 after selling out during the quarter.
  • Horizon Financial Services sold 430 Halozyme shares in Q4 2021, an estimated $17K.
  • Horizon Financial Services first reported a position in Halozyme in Q3 2020 and held it in 5 quarters.
  • Horizon Financial Services's Halozyme position peaked at $59K in Q2 2021.
  • 324 funds tracked by Wall St. Rank held Halozyme as of Q4 2021.

Based on Horizon Financial Services's 13F filing for Q4 2021, filed 31 Jan 2022.